• Home>
  • Stocks>
  • Lincoln Pharmaceuticals Ltd Share Price
Lincoln Pharmaceuticals Ltd share price logo

Lincoln Pharmaceuticals Ltd Share Price

NSE: LINCOLN

BSE: 531633

Small Cap

Healthcare Sector

₹527.35

+3.20

(+0.61%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Lincoln Pharmaceuticals Ltd Stock Performance

as on October 24, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹523
    ₹536.45
    downward going graph

    0.82%

    Downside

    1.73%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹499
    ₹979.5
    downward going graph

    5.38%

    Downside

    85.74%

    Upside

    downward going graph

Lincoln Pharmaceuticals Ltd share price movements today

Previous Close
₹524.15
Open
₹527.00
Volume
24.48K
Upper Circuit
₹628.95
Lower Circuit
₹419.35
Day's Low - High
₹523 - ₹536.45
52 Week Low - High
₹499 - ₹979.5

Lincoln Pharmaceuticals Ltd Historical Returns

1 Month Return
-3.04 %
3 Month Return
-2.77 %
1 Year Return
-18.65 %
3 Year Return
+ 78.76 %
5 Year Return
+ 142.4 %

Lincoln Pharmaceuticals Ltd Fundamentals

as on October 24, 2025 at 4:01 pm IST

Market Cap

₹1,056.27 Cr

Return on Equity (ROE)

13.02

PE Ratio (TTM)

12.23

Return on capital employed (ROCE)

17.42

Industry PE ratio

42.18

Beta (LTM)

1.16

P/B Ratio

1.64

Dividend Yield

0.33

PEG Ratio

-2.11

Quarterly Earnings Growth YOY

16.94

EPS (TTM)

41.11

Sector

Pharmaceuticals

Book Value

335.34

Technical Analysis

Bearish

View Technical Analysis

Lincoln Pharmaceuticals Ltd Stock Valuation

as on October 24, 2025 at 4:01 pm IST

Lincoln Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.58x)

March 23, 2020

Today (12.23x)

October 24, 2025

Industry (42.18x)

October 24, 2025

Highest (19.77x)

December 9, 2024

LowHigh

Today’s Price to Earnings Ratio: 12.23x

Lincoln Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lincoln Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
NA1,056.2728.48%0.5082623
Caplin Point Laboratories Ltd image
Caplin Point Laboratories Ltd
BUY15,149.8956.05%0.515411,937
Bharat Parenterals Ltd image
Bharat Parenterals Ltd
NA860.4344.57%0.69-44340
Kimia Biosciences Ltd image
Kimia Biosciences Ltd
NA160.201.23%0.009118
Jagsonpal Pharmaceuticals Ltd image
Jagsonpal Pharmaceuticals Ltd
NA1,438.52257.46%0.0055268
See all

Lincoln Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Lincoln Pharmaceuticals Ltd Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Lincoln Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
133.77
112.46
135.62
155.99
146.45
142.49
147.28
161.21
146.55
168.18
154.07
Other Income
6.36
3.9
7.69
8.69
11.02
7.02
10.41
9.98
8.97
-6.88
15.27
Total Income
140.12
116.36
143.31
164.68
157.47
149.51
157.69
171.19
155.52
161.3
169.34
Expenses
107.02
95.82
114.9
124.84
116.79
124.11
124.55
132.83
122.89
141.46
130.26
Operating Profit
26.75
16.64
20.72
31.15
29.66
18.38
22.73
28.38
23.66
26.72
23.81
Operating Profit Margin %
20%
14.8%
15.28%
19.97%
20.25%
12.9%
15.43%
17.6%
16.14%
15.89%
15.45%
Profit Before Interest, Tax and Depreciation
33.11
20.54
28.41
39.84
40.68
25.4
33.14
38.36
32.63
19.84
39.08
Interest
0.33
1.15
0.42
0.39
0.15
0.5
0.44
0.35
0.73
0.37
0.21
Depreciation
2.26
2.41
2.55
2.58
2.81
2.69
3.22
3.22
3.22
3.23
3.48
Profit Before Tax
30.52
16.98
25.44
36.87
37.72
22.21
29.48
34.79
28.68
16.24
35.39
Tax Paid
8.91
4.41
6.43
9.21
9.67
3.62
5.8
8.45
7.92
4.67
7.71
Profit After Tax
21.61
12.56
19.01
27.65
28.04
18.6
23.67
26.33
20.77
11.58
27.68
Total Net profit including share of profit / Loss from associate company
21.61
12.56
19.01
27.65
28.04
18.6
23.67
26.33
20.77
11.58
27.68
EPS
10.79
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
Actual EPS
10.79
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
Adjusted EPS
10.79
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
Diluted EPS
10.79
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82

Lincoln Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
360.26
360.61
366.15
386.49
424.19
472.12
510.31
580.55
623.23
Other Income
2.73
5.45
5.63
11.04
5.66
10
22.47
34.42
22.48
Total Income
362.99
366.07
371.78
397.53
429.85
482.12
532.78
614.97
645.71
Expenses
313.48
308.3
298.91
320.95
337.01
376.64
421.11
480.64
521.74
Operating Profit
46.78
52.31
67.24
65.54
87.18
95.48
89.2
99.91
101.49
Operating Profit Margin %
12.99%
14.51%
18.36%
16.96%
20.55%
20.22%
17.48%
17.21%
16.28%
Profit Before Interest, Tax and Depreciation
49.51
57.77
72.87
76.58
92.84
105.48
111.68
134.33
123.97
Interest
6.66
5.41
4
2.02
1.56
1.45
2.03
1.46
1.88
Depreciation
5.51
6.11
6.68
7.33
7.56
8.09
9.17
10.62
12.9
Profit Before Tax
37.34
46.25
62.19
67.23
83.72
95.94
100.48
122.25
109.19
Tax Paid
9.2
11.59
13.45
15.77
21.47
26.58
27.58
28.93
26.85
Profit After Tax
28.13
34.65
48.74
51.47
62.25
69.36
72.9
93.3
82.35
Total Net profit including share of profit / Loss from associate company
28.13
34.65
48.74
51.47
62.25
69.36
72.9
93.3
82.35
EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Actual EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Adjusted EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Diluted EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11

Lincoln Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
44.8
25.04
26.63
52.84
75.42
69.27
76.13
39.26
63.22
93.02
Cash Flow from Investing Activities
-41.7
-25.49
-11.78
-18.18
-30.88
-64.22
-78.08
-36.64
-57.34
-78.95
Cash Flow from Financing Activities
-3.42
0.3
-11.41
-35.76
-37.75
-5.74
-2.56
-4.49
-5.17
-6.41
Net Cash Flow
-0.32
-0.14
3.45
-1.11
6.77
-0.7
-4.5
-1.88
0.7
7.67

Lincoln Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
46.34%
47%
48.67%
50.53%
49.8%
49.53%
49.78%
49.78%
49.78%
49.78%
49.78%
49.78%
DII
0%
0%
0%
0%
0%
0.05%
0.04%
0%
0%
0.01%
0.01%
0.01%
FII
0%
0%
0%
2.59%
0%
3.93%
3.95%
5.19%
5.16%
5%
5.14%
4.72%
Public
52.22%
51.73%
49.58%
46.88%
46.91%
46.49%
46.24%
45.03%
45.06%
45.22%
45.07%
45.49%
Total Outstanding Shares
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
Total Shareholders
29,846
29,088
27,480
28,670
29,316
31,375
29,967
31,330
31,848
31,867
31,784
32,370

Mutual Funds that own Lincoln Pharmaceuticals Ltd Stock

Check out the Mutual Funds with significant holdings in Lincoln Pharmaceuticals Ltd.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.04%
130

Lincoln Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Lincoln Pharmaceuticals Ltd.

  • Lincoln Pharmaceuticals Ltd Earnings Results

    Lincoln Pharmaceuticals Ltd’s net profit jumped 16.94% since last year same period to ₹27.68Cr in the Q1 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 139.03% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Lincoln Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 per share on 22 May 2025 - translating a dividend yield of 0.34%.

    Read More about Dividends

Indices Featuring Lincoln Pharmaceuticals Ltd Stock

Check stock indices that include Lincoln Pharmaceuticals Ltd.

BSE Healthcare

₹44,883.76

-0.75 (▲-337.82%)

BSE Small-Cap

₹53,516.80

-0.19 (▲-99.91%)

Insights on Lincoln Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 155.52 Cr → 169.34 Cr (in ₹), with an average increase of 4.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 11.58 Cr → 27.68 Cr (in ₹), with an average increase of 58.2% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.07% to 45.49% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 127.0% return, outperforming this stock by 48.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 14.1% return, outperforming this stock by 32.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.78% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 5.14% to 4.72% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, LINCOLN stock has moved down by -11.1%

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals, established in January 1979 as a partnership firm, was converted into a public limited company in January 1995. Primarily set up to manufacture pharmaceutical formulations such as tablets, capsules, syrups and ointments, they also obtained products from other licensed manufacturers to meet the demands of small volume parenterals. In order to increase production capacity, the company set up a modern formulation plant in Khatraj, Gujarat, and established an in-house laboratory for quality control and R&D. To fund its projects, the firm launched a public issue in February 1996, and in the year 2000, they were granted ISO 9002 and WHO certification. As a result, Lincoln Pharmaceuticals is now a leading manufacturer of quality pharmaceuticals that is continuously working to improve its operations.

Revenue: ₹154.07Cr as on June 2025 (Q1 FY26)
Net Profit: ₹27.68Cr as on June 2025 (Q1 FY26)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
OrganisationLincoln Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOKishorbhai M Shah
E-voting on sharesClick here to vote

FAQs

What is Lincoln Pharmaceuticals Ltd share price today?

Lincoln Pharmaceuticals Ltd share price today stands at ₹527.35 as on at the close of the market. Lincoln Pharmaceuticals Ltd share today touched a day high of ₹536.45 and a low of ₹523.

What is the 52 week high and 52 week low range for Lincoln Pharmaceuticals Ltd share?

Lincoln Pharmaceuticals Ltd touched a 52 week high of ₹979.5 and a 52 week low of ₹499. Lincoln Pharmaceuticals Ltd share price today i.e. is closed at ₹527.35, which is -46.16% down from its 52 week high and 5.68% up from its 52 week low.

What is Lincoln Pharmaceuticals Ltd's market capitalisation today?

Lincoln Pharmaceuticals Ltd market capitalisation is ₹1,056.27 Cr as on .

How to buy Lincoln Pharmaceuticals Ltd shares?

To buy Lincoln Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LINCOLN or Lincoln Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lincoln Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lincoln Pharmaceuticals Ltd trading volume today?

Lincoln Pharmaceuticals Ltd trading volume is 24.48K as on . This means that 24.48K shares of Lincoln Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.